Resources
All About Angel Investors
All About Venture Capitalists
Business Funding Resources
Small Business Funding
Startup Capital Needs
Business Plans & Proposals
Entrepreneur - New Business
Resources
Cancer Cure company w/products that deal w/ solid tumors and skin cancer..needs capital
Posted by: flytodaycheap.com on 7/22/2008 5:31:10 PM
Funding Needed:
Above $1mil 		Category:
Healthcare & Medical / Pharma 		Website :
Please login to view.
Location :
Atlanta, Georgia, USA 		Viewed : 105 times
Favorited : 0 times 		Share
Description:
Most people go through their entire life trying to just once make a major difference in the world we live in. The company you are reviewing today could do just that, MAKE A MAJOR DIFFERENCE IN CURING CANCER, THE #1 CAUSE OF DEATHS IN THE WORLD.

Allow me to introduce to you a company that has developed products that deal with SOLID TUMORS (Breast, prostate, testicle, lung and brain) and SKIN CANCER. Nothing like it exists to date. In addition, this company is also in the initial development of a drug candidate to treat Otosclerosis, a hereditary disease which causes progressive hearing loss.

PRODUCT #1: The first product dealing with solid tumors is patented and is currently in preclinical testing for cancer as well as in discovery and preclinical development for indications in diseases of immune orgin.

PRODUCT #2: The second product dealing with skin cancer (basal & squamous cell) and other dermatological indications, is also in preclinical discovery and development.

PRODUCT #3: The third product is in intial development of a drug candidate to treat Otosclerosis, which is a progressive hearing loss disease.

What makes this such an unusual company is that the company expects to generate a major shift in the way that cancer is treated. The products literally could replace chemotherapy as what this company is doing is providing the medical community with a medical innovation breakthrough.

Initial Results of a humanitarian pilot study of over 900 late/terminal stage patients show:

**********Product reduces tumor mass and/or stops tumor growth

********** 90% of patients showed immediate positive response to treatment

**********Proven to work much faster than most chemotherapeutical agents.

********** No significant side effects were observed in any of the patients

**********Substantial increase of Quality of Life for many patients

**********Compound is easy to produce and manufacturing costs are very low.

The goal of the company, upon raising the necessary funds is to initiate Phase I clinical trials with 30-40 patients with relapsed Brain Cancer. These patients have exhausted other treatments (surgery, radiotherapy and chemotherapy) and have approx. 2-4 months to live. Once completed, the company will file a Fast Track and Orphan Status with the FDA for an accelerated clinical program in Brain Cancer tumors, and either melanoma or pacreatic cancer. Upon completion of Phase I, monies raised will go for the completion of Phase II clinical study on 80-120 patients. If successful, the company projects over $380 Million in revenue the first year and over $1 Billion by year 4.

Management and the scientific advisory board reads like a "Whos Who".

We all know people who have cancer or have died from it. YOU CAN MAKE A DIFFERENCE.

I have quite a bit of information on this company, so don't be afraid to email me back.

 Digg It    Stumble It    Deli.icio.us
Respond
You must be a member to respond to this post. If you are a member , please login to respond.